Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intracerebral Microdialysis Study to Determine the Neuropharmacokinetics of Eribulin in Patients With Brain Tumors

NCT02338037 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT02338037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02338037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intracerebral Microdialysis Study to Determine the Neuropharmacokinetics of Eribulin in Patients With Brain Tumors
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 16, 2015
Completion date
March 15, 2024
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the adult brain, primary brain tumor